skip navigation

CrimeSolutions.gov

Add your conference to our Justice Events calendar

PUBLICATIONS

NCJRS Abstract

The document referenced below is part of the NCJRS Library collection.
To conduct further searches of the collection, visit the NCJRS Abstracts Database.

How to Obtain Documents
 
NCJ Number: NCJ 224072     Find in a Library
Title: InfoFacts: Club Drugs (GHB, Ketamine, and Rohypnol)
Corporate Author: National Institutes of Health
National Institute on Drug Abuse
United States of America
Date Published: 07/2010
Page Count: 4
Sale Source: National Institutes of Health
National Institute on Drug Abuse
6001 Executive Boulevard
Bethesda, MD 20892
United States of America
Document: HTML PDF 
Type: Issue Overview
Language: English
Country: United States of America
Annotation: Informational facts are presented on the club drugs: GHB (Gamma hydroxybutyrate), Ketamine and Rohypnol.
Abstract: Club drugs are a pharmacologically heterogeneous group of psychoactive compounds that tend to be abused by teens and young adults at nightclubs, bars, raves, or trance scenes. Three club drugs which are the focus of this fact sheet are: Gamma hydroxybutyrate (GHB), Rohypnol, and Ketamine. GHB is a central nervous system depressant used in the treatment of narcolepsy, a sleep disorder. Rohypnol began appearing in the United States in the early 1990s. It is a benzodiazepine, similar to Valium or Xanax, and is not approved for medical use in the United States. Ketamine is a dissociative anesthetic used mostly in veterinary practice. This fact sheet offers an overview of the drugs’ effects on the brain, as well as other associated medical consequences, such as coma, seizure, impaired motor function, and fatal respiratory problems and treatment options. The fact sheet concludes with national statistics obtained from the Monitoring the Future survey on widespread club drug abuse among adolescents. Notes, references
Main Term(s): Drug abuse
Index Term(s): Public information ; Drug effects ; Toxic reactions ; Drug information ; Drug treatment ; Controlled Substances ; Drug abuse education ; Designer drugs ; Drug statistics ; GHB (gammahydroxybutyrate)
Note: From NIDA InfoFacts
   
  To cite this abstract, use the following link:
https://www.ncjrs.gov/App/Publications/abstract.aspx?ID=246024

* A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's web site is provided.